Review



mouse anti catd  (Santa Cruz Biotechnology)


Bioz Verified Symbol Santa Cruz Biotechnology is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    Santa Cruz Biotechnology mouse anti catd
    Mouse Anti Catd, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 655 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse anti catd/product/Santa Cruz Biotechnology
    Average 96 stars, based on 655 article reviews
    mouse anti catd - by Bioz Stars, 2026-06
    96/100 stars

    Images



    Similar Products

    96
    Santa Cruz Biotechnology mouse anti catd
    Mouse Anti Catd, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse anti catd/product/Santa Cruz Biotechnology
    Average 96 stars, based on 1 article reviews
    mouse anti catd - by Bioz Stars, 2026-06
    96/100 stars
      Buy from Supplier

    90
    Santa Cruz Biotechnology mouse anti-catd
    Mouse Anti Catd, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse anti-catd/product/Santa Cruz Biotechnology
    Average 90 stars, based on 1 article reviews
    mouse anti-catd - by Bioz Stars, 2026-06
    90/100 stars
      Buy from Supplier

    94
    R&D Systems Hematology anti catd
    Anti Catd, supplied by R&D Systems Hematology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti catd/product/R&D Systems Hematology
    Average 94 stars, based on 1 article reviews
    anti catd - by Bioz Stars, 2026-06
    94/100 stars
      Buy from Supplier

    94
    R&D Systems catd
    Loss of NHE6 increases MVB fusion with the PM and exosome secretion. A , Representative TIRF image depicting MVB-PM fusion and exosome release as developed from . Widefield image of neuron cotransfected with mCherry <t>and</t> <t>CD63-pHluorin</t> expression constructs. White inset, Location of MVB-PM fusion and the zoomed in panels on the right. Each panel represents the progression of a CD63-pHluorin fusion event with the PM with the number of seconds indicated below the panel. Scale bars: large, 10 µm; small, 1 µm. B , Quantification of full MVB-PM fusion/exosome release events per cell over 5 min in WT and Nhe6 -/Y male littermate mouse primary hippocampal neurons at 14 DIV (WT n = 28 cells from 7 mice, Nhe6 -/Y n = 18 cells from 7 mice, 5 litters, p = 0.009, Glass's Δ = 2.27). C , Quantification of full MVB-PM fusion/exosome release events per cell over 5 min in WT and Nhe6 -/Y male mouse primary hippocampal neurons at 14 DIV under the following conditions: untreated (same as in B ), U18666A (positive control) (WT n = 14 cells from 5 mice, Nhe6 -/Y n = 14 cells from 5 mice, 3 litters), bafilomycin A1 (positive control) (WT n = 14 cells from 7 mice, Nhe6 -/Y n = 16 cells from 6 mice, 4 litters, Kruskal–Wallis test with Dunn's test: WT untreated compared with WT bafilomycin A1 p = 0.002, Glass's Δ = 3.04). D , E , CD63 western blot ( D ) and quantification ( E ) in WT and Nhe6 -/Y male littermate mouse primary hippocampal neurons at 14 DIV (WT n = 5 cultures, Nhe6 -/Y n = 5 cultures, 5 litters, p = 0.02, Glass's Δ = 1.68). F , Released β-Hex enzyme activity following short-term incubation in Tyrode's solution followed by treatment with either ionomycin or DMSO (WT n = 9, Nhe6 -/Y n = 9, 8 litters). G , Released <t>CatD</t> enzyme activity following short-term incubation in Tyrode's solution followed by treatment with either ionomycin or DMSO (WT n = 6, Nhe6 -/Y n = 6, 5 litters). H , Released LDH activity across all β-Hex (WT n = 5, Nhe6 -/Y n = 5, 5 litters) and CatD (WT n = 4, Nhe6 -/Y n = 4, 3 litters) experiments. Data are mean ± SEM. Unpaired two-tailed Student's t test ( C , WT- Nhe6 -/Y : bafilomycin A1) with Welch's correction ( E ), Mann–Whitney test ( B , C , WT- Nhe6 -/Y : U18666A), Kruskal–Wallis test with Dunn's test ( C , differences between treatments by genotype), two-way ANOVA with Tukey's multiple comparisons test ( F , G , H ).
    Catd, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/catd/product/R&D Systems
    Average 94 stars, based on 1 article reviews
    catd - by Bioz Stars, 2026-06
    94/100 stars
      Buy from Supplier

    94
    R&D Systems actin a3853
    Figure 12. Loss of NHE6 increases MVB fusion with the PM and exosome secretion. A, Representative TIRF image depicting MVB-PM fusion and exosome release as developed from Verweij et al. (2018). Widefield image of neuron cotransfected with mCherry <t>and</t> <t>CD63-pHluorin</t> expression constructs. White inset, Location of MVB-PM fusion and the zoomed in panels on the right. Each panel represents the progression of a CD63-pHluorin fusion event with the PM with the number of seconds indicated below the panel. Scale bars: large, 10mm; small, 1 mm. B, Quantification of full MVB-PM fusion/exosome release events per cell over 5 min in WT and Nhe6-/Y male littermate mouse primary hippocampal neurons at 14 DIV (WT n = 28 cells from 7 mice, Nhe6-/Y n = 18 cells from 7 mice, 5 litters, p = 0.009, Glass’s D = 2.27). C, Quantification of full MVB-PM fusion/exosome release events per cell over 5 min in WT and Nhe6-/Y male mouse primary hippocampal neurons at 14 DIV under the following conditions: untreated (same as in B), U18666A (positive control) (WT n = 14 cells from 5 mice, Nhe6-/Y n = 14 cells from 5 mice, 3 litters), bafilomycin A1 (positive control) (WT n = 14 cells from 7 mice, Nhe6-/Y n = 16 cells from 6 mice, 4 litters, Kruskal–Wallis test with Dunn’s test: WT untreated compared with WT bafilomycin A1 p = 0.002, Glass’s D = 3.04). D, E, CD63 western blot (D) and quantification (E) in WT and Nhe6-/Y male littermate mouse primary hippocampal neurons at 14 DIV (WT n = 5 cultures, Nhe6-/Y n = 5 cultures, 5 litters, p = 0.02, Glass’s D = 1.68). F, Released b -Hex enzyme activity following short-term incubation in Tyrode’s solution followed by treatment with either ionomycin or DMSO (WT n = 9, Nhe6-/Y n = 9, 8 litters). G, Released <t>CatD</t> enzyme activity following short-term incubation in Tyrode’s solution followed by treatment with either ionomycin or DMSO (WT n = 6, Nhe6-/Y n = 6, 5 litters). H, Released LDH activity across all b -Hex (WT n = 5, Nhe6-/Y n = 5, 5 litters) and CatD (WT n = 4, Nhe6-/Y n = 4, 3 litters) experiments. Data are mean 6 SEM. Unpaired two-tailed Student’s t test (C, WT-Nhe6-/Y: bafilomycin A1) with Welch’s correction (E), Mann–Whitney test (B,C, WT-Nhe6-/Y: U18666A), Kruskal–Wallis test with Dunn’s test (C, differences between treatments by genotype), two-way ANOVA with Tukey’s multiple comparisons test (F,G,H).
    Actin A3853, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/actin a3853/product/R&D Systems
    Average 94 stars, based on 1 article reviews
    actin a3853 - by Bioz Stars, 2026-06
    94/100 stars
      Buy from Supplier

    Image Search Results


    Loss of NHE6 increases MVB fusion with the PM and exosome secretion. A , Representative TIRF image depicting MVB-PM fusion and exosome release as developed from . Widefield image of neuron cotransfected with mCherry and CD63-pHluorin expression constructs. White inset, Location of MVB-PM fusion and the zoomed in panels on the right. Each panel represents the progression of a CD63-pHluorin fusion event with the PM with the number of seconds indicated below the panel. Scale bars: large, 10 µm; small, 1 µm. B , Quantification of full MVB-PM fusion/exosome release events per cell over 5 min in WT and Nhe6 -/Y male littermate mouse primary hippocampal neurons at 14 DIV (WT n = 28 cells from 7 mice, Nhe6 -/Y n = 18 cells from 7 mice, 5 litters, p = 0.009, Glass's Δ = 2.27). C , Quantification of full MVB-PM fusion/exosome release events per cell over 5 min in WT and Nhe6 -/Y male mouse primary hippocampal neurons at 14 DIV under the following conditions: untreated (same as in B ), U18666A (positive control) (WT n = 14 cells from 5 mice, Nhe6 -/Y n = 14 cells from 5 mice, 3 litters), bafilomycin A1 (positive control) (WT n = 14 cells from 7 mice, Nhe6 -/Y n = 16 cells from 6 mice, 4 litters, Kruskal–Wallis test with Dunn's test: WT untreated compared with WT bafilomycin A1 p = 0.002, Glass's Δ = 3.04). D , E , CD63 western blot ( D ) and quantification ( E ) in WT and Nhe6 -/Y male littermate mouse primary hippocampal neurons at 14 DIV (WT n = 5 cultures, Nhe6 -/Y n = 5 cultures, 5 litters, p = 0.02, Glass's Δ = 1.68). F , Released β-Hex enzyme activity following short-term incubation in Tyrode's solution followed by treatment with either ionomycin or DMSO (WT n = 9, Nhe6 -/Y n = 9, 8 litters). G , Released CatD enzyme activity following short-term incubation in Tyrode's solution followed by treatment with either ionomycin or DMSO (WT n = 6, Nhe6 -/Y n = 6, 5 litters). H , Released LDH activity across all β-Hex (WT n = 5, Nhe6 -/Y n = 5, 5 litters) and CatD (WT n = 4, Nhe6 -/Y n = 4, 3 litters) experiments. Data are mean ± SEM. Unpaired two-tailed Student's t test ( C , WT- Nhe6 -/Y : bafilomycin A1) with Welch's correction ( E ), Mann–Whitney test ( B , C , WT- Nhe6 -/Y : U18666A), Kruskal–Wallis test with Dunn's test ( C , differences between treatments by genotype), two-way ANOVA with Tukey's multiple comparisons test ( F , G , H ).

    Journal: The Journal of Neuroscience

    Article Title: Loss of Christianson Syndrome Na + /H + Exchanger 6 (NHE6) Causes Abnormal Endosome Maturation and Trafficking Underlying Lysosome Dysfunction in Neurons

    doi: 10.1523/JNEUROSCI.1244-20.2021

    Figure Lengend Snippet: Loss of NHE6 increases MVB fusion with the PM and exosome secretion. A , Representative TIRF image depicting MVB-PM fusion and exosome release as developed from . Widefield image of neuron cotransfected with mCherry and CD63-pHluorin expression constructs. White inset, Location of MVB-PM fusion and the zoomed in panels on the right. Each panel represents the progression of a CD63-pHluorin fusion event with the PM with the number of seconds indicated below the panel. Scale bars: large, 10 µm; small, 1 µm. B , Quantification of full MVB-PM fusion/exosome release events per cell over 5 min in WT and Nhe6 -/Y male littermate mouse primary hippocampal neurons at 14 DIV (WT n = 28 cells from 7 mice, Nhe6 -/Y n = 18 cells from 7 mice, 5 litters, p = 0.009, Glass's Δ = 2.27). C , Quantification of full MVB-PM fusion/exosome release events per cell over 5 min in WT and Nhe6 -/Y male mouse primary hippocampal neurons at 14 DIV under the following conditions: untreated (same as in B ), U18666A (positive control) (WT n = 14 cells from 5 mice, Nhe6 -/Y n = 14 cells from 5 mice, 3 litters), bafilomycin A1 (positive control) (WT n = 14 cells from 7 mice, Nhe6 -/Y n = 16 cells from 6 mice, 4 litters, Kruskal–Wallis test with Dunn's test: WT untreated compared with WT bafilomycin A1 p = 0.002, Glass's Δ = 3.04). D , E , CD63 western blot ( D ) and quantification ( E ) in WT and Nhe6 -/Y male littermate mouse primary hippocampal neurons at 14 DIV (WT n = 5 cultures, Nhe6 -/Y n = 5 cultures, 5 litters, p = 0.02, Glass's Δ = 1.68). F , Released β-Hex enzyme activity following short-term incubation in Tyrode's solution followed by treatment with either ionomycin or DMSO (WT n = 9, Nhe6 -/Y n = 9, 8 litters). G , Released CatD enzyme activity following short-term incubation in Tyrode's solution followed by treatment with either ionomycin or DMSO (WT n = 6, Nhe6 -/Y n = 6, 5 litters). H , Released LDH activity across all β-Hex (WT n = 5, Nhe6 -/Y n = 5, 5 litters) and CatD (WT n = 4, Nhe6 -/Y n = 4, 3 litters) experiments. Data are mean ± SEM. Unpaired two-tailed Student's t test ( C , WT- Nhe6 -/Y : bafilomycin A1) with Welch's correction ( E ), Mann–Whitney test ( B , C , WT- Nhe6 -/Y : U18666A), Kruskal–Wallis test with Dunn's test ( C , differences between treatments by genotype), two-way ANOVA with Tukey's multiple comparisons test ( F , G , H ).

    Article Snippet: The following antibodies were used for western blot: actin (Sigma, A3853, Ms, 1:1000), CatD (R&D Systems, AF1029, Gt, 1:1000), CD63 (Abcam, EPR21151-ab217345, Rb, 1:1000), ci-mannose 6-phosphate receptor (M6PR) (Cell Signaling Technology, 14364S, Rb, 1:500), GAPDH (Sigma, G8795, Ms, 1:40 000), LAMP1 (DSHB, 1D4B, Rt, 1:1000), RAB5 (Cell Signaling Technology, 3547, Rb, 1:1000), and RAB7 (Sigma, R8779, Ms, 1:1000).

    Techniques: Expressing, Construct, Positive Control, Western Blot, Activity Assay, Incubation, Two Tailed Test, MANN-WHITNEY

    Figure 12. Loss of NHE6 increases MVB fusion with the PM and exosome secretion. A, Representative TIRF image depicting MVB-PM fusion and exosome release as developed from Verweij et al. (2018). Widefield image of neuron cotransfected with mCherry and CD63-pHluorin expression constructs. White inset, Location of MVB-PM fusion and the zoomed in panels on the right. Each panel represents the progression of a CD63-pHluorin fusion event with the PM with the number of seconds indicated below the panel. Scale bars: large, 10mm; small, 1 mm. B, Quantification of full MVB-PM fusion/exosome release events per cell over 5 min in WT and Nhe6-/Y male littermate mouse primary hippocampal neurons at 14 DIV (WT n = 28 cells from 7 mice, Nhe6-/Y n = 18 cells from 7 mice, 5 litters, p = 0.009, Glass’s D = 2.27). C, Quantification of full MVB-PM fusion/exosome release events per cell over 5 min in WT and Nhe6-/Y male mouse primary hippocampal neurons at 14 DIV under the following conditions: untreated (same as in B), U18666A (positive control) (WT n = 14 cells from 5 mice, Nhe6-/Y n = 14 cells from 5 mice, 3 litters), bafilomycin A1 (positive control) (WT n = 14 cells from 7 mice, Nhe6-/Y n = 16 cells from 6 mice, 4 litters, Kruskal–Wallis test with Dunn’s test: WT untreated compared with WT bafilomycin A1 p = 0.002, Glass’s D = 3.04). D, E, CD63 western blot (D) and quantification (E) in WT and Nhe6-/Y male littermate mouse primary hippocampal neurons at 14 DIV (WT n = 5 cultures, Nhe6-/Y n = 5 cultures, 5 litters, p = 0.02, Glass’s D = 1.68). F, Released b -Hex enzyme activity following short-term incubation in Tyrode’s solution followed by treatment with either ionomycin or DMSO (WT n = 9, Nhe6-/Y n = 9, 8 litters). G, Released CatD enzyme activity following short-term incubation in Tyrode’s solution followed by treatment with either ionomycin or DMSO (WT n = 6, Nhe6-/Y n = 6, 5 litters). H, Released LDH activity across all b -Hex (WT n = 5, Nhe6-/Y n = 5, 5 litters) and CatD (WT n = 4, Nhe6-/Y n = 4, 3 litters) experiments. Data are mean 6 SEM. Unpaired two-tailed Student’s t test (C, WT-Nhe6-/Y: bafilomycin A1) with Welch’s correction (E), Mann–Whitney test (B,C, WT-Nhe6-/Y: U18666A), Kruskal–Wallis test with Dunn’s test (C, differences between treatments by genotype), two-way ANOVA with Tukey’s multiple comparisons test (F,G,H).

    Journal: The Journal of Neuroscience

    Article Title: Loss of Christianson Syndrome Na+/H+ Exchanger 6 (NHE6) Causes Abnormal Endosome Maturation and Trafficking Underlying Lysosome Dysfunction in Neurons

    doi: 10.1523/jneurosci.1244-20.2021

    Figure Lengend Snippet: Figure 12. Loss of NHE6 increases MVB fusion with the PM and exosome secretion. A, Representative TIRF image depicting MVB-PM fusion and exosome release as developed from Verweij et al. (2018). Widefield image of neuron cotransfected with mCherry and CD63-pHluorin expression constructs. White inset, Location of MVB-PM fusion and the zoomed in panels on the right. Each panel represents the progression of a CD63-pHluorin fusion event with the PM with the number of seconds indicated below the panel. Scale bars: large, 10mm; small, 1 mm. B, Quantification of full MVB-PM fusion/exosome release events per cell over 5 min in WT and Nhe6-/Y male littermate mouse primary hippocampal neurons at 14 DIV (WT n = 28 cells from 7 mice, Nhe6-/Y n = 18 cells from 7 mice, 5 litters, p = 0.009, Glass’s D = 2.27). C, Quantification of full MVB-PM fusion/exosome release events per cell over 5 min in WT and Nhe6-/Y male mouse primary hippocampal neurons at 14 DIV under the following conditions: untreated (same as in B), U18666A (positive control) (WT n = 14 cells from 5 mice, Nhe6-/Y n = 14 cells from 5 mice, 3 litters), bafilomycin A1 (positive control) (WT n = 14 cells from 7 mice, Nhe6-/Y n = 16 cells from 6 mice, 4 litters, Kruskal–Wallis test with Dunn’s test: WT untreated compared with WT bafilomycin A1 p = 0.002, Glass’s D = 3.04). D, E, CD63 western blot (D) and quantification (E) in WT and Nhe6-/Y male littermate mouse primary hippocampal neurons at 14 DIV (WT n = 5 cultures, Nhe6-/Y n = 5 cultures, 5 litters, p = 0.02, Glass’s D = 1.68). F, Released b -Hex enzyme activity following short-term incubation in Tyrode’s solution followed by treatment with either ionomycin or DMSO (WT n = 9, Nhe6-/Y n = 9, 8 litters). G, Released CatD enzyme activity following short-term incubation in Tyrode’s solution followed by treatment with either ionomycin or DMSO (WT n = 6, Nhe6-/Y n = 6, 5 litters). H, Released LDH activity across all b -Hex (WT n = 5, Nhe6-/Y n = 5, 5 litters) and CatD (WT n = 4, Nhe6-/Y n = 4, 3 litters) experiments. Data are mean 6 SEM. Unpaired two-tailed Student’s t test (C, WT-Nhe6-/Y: bafilomycin A1) with Welch’s correction (E), Mann–Whitney test (B,C, WT-Nhe6-/Y: U18666A), Kruskal–Wallis test with Dunn’s test (C, differences between treatments by genotype), two-way ANOVA with Tukey’s multiple comparisons test (F,G,H).

    Article Snippet: The following antibodies were used for western blot: actin (Sigma, A3853, Ms, 1:1000), CatD (R&D Systems, AF1029, Gt, 1:1000), CD63 (Abcam, EPR21151-ab217345, Rb, 1:1000), ci-mannose 6-phosphate receptor (M6PR) (Cell Signaling Technology, 14364S, Rb, 1:500), GAPDH (Sigma, G8795, Ms, 1:40 000), LAMP1 (DSHB, 1D4B, Rt, 1:1000), RAB5 (Cell Signaling Technology, 3547, Rb, 1:1000), and RAB7 (Sigma, R8779, Ms, 1:1000).

    Techniques: Expressing, Construct, Positive Control, Western Blot, Activity Assay, Incubation, Two Tailed Test, MANN-WHITNEY